A series of zinc-containing heterodimetallic complexes wereprepared by using the dinucleating ligand XDK[H
2XDK =
m-xylylenediaminebis(Kemp's triacid imide)]. Mononuclear[Zn(XDK)(H
2O)] (
1) reacts with1equiv of M(acac)
2·2H
2O (acac =2,4-pentanedionate) to afford the heterodimetalliccompounds[Zn
IIM
II(XDK)(acac)
2(CH
3OH)
2]·H
2O(
2·H
2O, M = Co, 65% isolated yield;
3·H
2O, M = Mn, 54%;
4·H
2O, M= Fe, 30%;
5·H
2O, M = Ni, 32%). Asdetermined by X-ray crystallography,
2-
5 eachcontain a Zn
IIM
II dinuclearcore bridged by XDK and acac ligands. The zinc and M atoms havetrigonal bipyramidal and octahedral geometries,respectively. The Zn···M separations depend on the metal ionin the octahedral site (
2, M = Co, 3.440(2) Å;
3,M = Mn, 3.517(1) Å;
4, M = Fe, 3.492(1) Å;
5, M = Ni, 3.397(1) Å), a variation which iscorrelated with theionic radius of the high-spin octahedral metal ion. The reactionof
2 with diphenyl hydrogen phosphate affordedthe bis(phosphate) complex[ZnCo(XDK){
-
2-(PhO)
2PO
2}{
1-(PhO)
2PO
2}(CH
3OH)
2(H
2O)](
7, 49% yield). TheZnCo center is bridged by the XDK through its two carboxylate groupsand by a diphenyl phosphate ligand. Theother diphenyl phosphate is terminally coordinated to the zinc atom ina monodentate fashion. The Zn···Cointeratomic distance is 3.846(1) Å. An analogousbis(phosphate) homodinuclear complex,[Zn
2(XDK){
-
2-(PhO)
2PO
2}{
1-(PhO)
2PO
2}(CH
3OH)
2(H
2O)](
8), was prepared by reacting[Zn
2(XDK)(acac)
2(CH
3OH)
2](
6) withdiphenyl hydrogen phosphate in 64% yield. Compound
8,which is isomorphous with
7, has anasymmetricaldizinc core bridged by XDK and a phosphate ligand (Zn···Zn= 3.869(2) Å). The monodentate diphenylphosphateligand dissociates from the dimetallic center of
8 insolution, as revealed by molar conductivity and
1Hand
31P{
1H} NMR spectroscopic studies.The resulting free phosphate ligand exchanges with the bridgingone inmethanol-
d4. The present results provide auseful synthetic route to carboxylate-bridgedheterodimetalliccompounds, which are potential models for the active centers innonredox metalloproteins. Crystal data are asfollows.
2: monoclinic,
P2
1/c,
a =17.7
25(7) Å,
b = 12.354(4) Å,
c =21.815(6) Å,
= 90.45(3)
,
V =4777(2)Å
3,
Z = 4;
R = 0.049 and
Rw = 0.051 for 3884 reflections with
I > 3
(
I).
3: monoclinic,
P2
1/c,
a =17.292(2)Å,
b = 12.450(1) Å,
c = 21.717(2)Å,
= 91.464(7)
,
V = 4673.9(7)Å
3,
Z = 4;
R = 0.046 and
Rw = 0.051 for3876 reflections.
4: monoclinic,
P2
1/c,
a =17.630(1) Å,
b = 12.374(2) Å,
c =21.771(2) Å,
= 90.306(8)
,
V = 4749.4(7) Å
3,
Z = 4;
R = 0.041 and
Rw = 0.049 for 3248reflections.
5: monoclinic,
P2
1/c,
a =17.817(2)Å,
b = 12.241(3) Å,
c = 21.786(2)Å,
= 91.043(9)
,
V = 4
751(1)Å
3,
Z = 4;
R = 0.050 and
Rw = 0.058 for4497 reflections.
7·CH
3OH:monoclinic,
P2
1/n,
a =18.812(2) Å,
b = 16.156(2) Å,
c =21.760(2) Å,
=112.836(9)
,
V = 6095(1) Å
3,
Z = 4;
R = 0.055 and
Rw = 0.064 for 5843 reflections.
8·CH
3OH: monoclinic,
P2
1/n,
a =18.845(6) Å,
b = 16.105(3) Å,
c =21.776(3) Å,
= 112.78(2)
,
V =6091(2) Å
3,
Z = 4;
R =0.055and
Rw = 0.061 for 5189reflections.